Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is uncomfortable, but it’s often not serious.

often without treatment, or they may come and go for up to 6 weeks. Doctors refer to these hives as "acute urticaria." Hives that recur several times a week for longer than 6 weeks are called ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

Urticarial vasculitis represents 5% to 10% of cases of chronic urticaria, characterized histologically by the presence of vasculitis on skin biopsy. Clinically it tends to last longer than ...

The mainstay of treatment for urticaria is oral antihistamines as they reduce itch, wheal duration and numbers. Management is better achieved by taking antihistamines daily, not just when the ...

Please provide your email address to receive an email when new articles are posted on . Briquilimab targets c-Kit to address mast cell diseases. Patients saw substantial reductions in tryptase as ...

Ever come up in hives after working out ... can help to diagnose and treat this condition.” Treatments for exercise-induced urticaria may include antihistamines, as well as other medications ...

Sanofi and Regeneron have reported disappointing results in a trial of Dupixent in people with chronic spontaneous urticaria ... treatment, Novartis/Roche's Xolair. CSU is a severe form of hives ...

Considering taking supplements to treat urticaria? Below is a list of common natural remedies used to treat or reduce the symptoms of urticaria. Follow the links to read common uses, side effects ...

These chronic hives conditions represent a significant ... and its ability to navigate the competitive landscape of urticaria treatment. While challenges remain, including weak gross profit ...

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.

8. Results were from the ongoing phase Ib/IIa study of the monoclonal antibody and lead candidate briquilimab in treating chronic spontaneous urticaria, often referred to as hives. The results showed ...